Yutaka Tagaya

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Bioniz, LLC, Bioniz Therapeutics, Inc.. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Tagaya. Retrieved from https://idiyas.com/inventor/yutaka-tagaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 5)

% Patents Active = 84.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 88(Granted Patents)

Company Filing History:

Bioniz Therapeutics, Inc.

patents

Years Active: 2013-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12030936 - Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders (2024-07-09),

2. 11834519 - Compositions and methods for modulating γ-c-cytokine activity (2023-12-05),

3. 11708392 - Peptide conjugates (2023-07-25),

4. 11462297 - Selective peptide antagonists (2022-10-04),

5. 10854312 - Selective peptide antagonists (2020-12-01),

6. 10808009 - Peptide conjugates (2020-10-20),

7. 10227382 - Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity (2019-03-12),

8. 9959384 - Methods of developing selective peptide antagonists (2018-05-01),

9. 9951105 - Methods of developing selective peptide antagonists (2018-04-24),

10. 9675672 - Compositions and methods for modulating gamma-C-cytokine activity (2017-06-13),

11. 9133244 - Compositions and methods for modulating gamma-c-cytokine activity (2015-09-15),

12. 9133243 - Compositions and methods for modulating γ-c-cytokine activity (2015-09-15),

13. 8455449 - Compositions and methods for modulating γ-c-cytokine activity (2013-06-04),

Title: Yutaka Tagaya: Innovator in Cytokine Research

Introduction

Yutaka Tagaya is a prominent inventor based in Rockville, MD, known for his significant contributions to the field of cytokine research. With a total of 13 patents to his name, he has made strides in developing therapeutic methods for various human diseases.

Latest Patents

Among his latest patents, Tagaya has focused on modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and related disorders. His work involves the γc-family cytokines, including Interleukin-2 (IL-2), Interleukin-4 (IL-4), Interleukin-7 (IL-7), Interleukin-9 (IL-9), Interleukin-15 (IL-15), and Interleukin-21 (IL-21). These cytokines are linked to significant human diseases, and his patents describe compositions, methods, and kits aimed at inhibiting or treating alopecia-related disorders. Additionally, he has developed compositions and methods for modulating γc-cytokine activity, which are valuable in treating leukemia, autoimmune diseases, and other serious conditions.

Career Highlights

Throughout his career, Yutaka Tagaya has worked with notable companies such as Bioniz, LLC and Bioniz Therapeutics, Inc. His innovative approaches have positioned him as a key figure in the research and development of cytokine-related therapies.

Collaborations

Tagaya has collaborated with various professionals in his field, including his coworker Nazli Azimi, to advance research and development in cytokine signaling.

Conclusion

Yutaka Tagaya's work in cytokine research has led to significant advancements in the treatment of various diseases, showcasing his dedication to innovation and therapeutic development. His contributions continue to impact the medical field positively.

Profile summary based on public USPTO records.